SCHEMBL9813617

SCHEMBL9813617

COc1cccc(C)c1NC(=O)C=C1SCC(=O)N1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.71
▸ TDP1 Q9NUW8 1/20 0.71
▸ PSMD14 O00487 1/20 0.53
▸ MAPT P10636 3/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ ATM Q13315 1/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ DRD4 P21917 2/20 0.38
▸ PKM P14618 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813610 1.00 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14MAPTCLK1
SCHEMBL9813566 0.90 PSMD14 (0.61) ALDH1A1TDP1PSMD14MAPTATM
SCHEMBL9813569 0.90 PSMD14 (0.61) ALDH1A1TDP1PSMD14MAPTATM
Ralitoline SCHEMBL635346 0.84 PSMD14 (0.55) ALDH1A1TDP1PSMD14GAA
Ralitoline SCHEMBL9813595 0.84 PSMD14 (0.55) ALDH1A1TDP1PSMD14GAA
SCHEMBL10853625 0.83 PSMD14 (0.60) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL9813540 0.83 PSMD14 (0.60) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL10851899 0.81 PSMD14 (0.55) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL10851908 0.81 PSMD14 (0.55) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL9813607 0.81 PSMD14 (0.51) ALDH1A1TDP1PSMD14MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback